Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours Β· Estimated delivery Aug 13 - Aug 18
Contact Us Dihexa (PNB-0408) is a synthetic heptapeptide analogue of angiotensin IV designed to interact with the hepatocyte growth factor (HGF)/c-Met signaling system
Research shows that overexpression of PER1 sensitizes human cancer cells to the effects of DNA damage-induced apoptosis
FDA specifically evaluated the free base and acetate as distinct bulk drug substances
For more information, visit Chicago Arthritis and Regenerative Medicine and explore how peptide therapy can support your health goals
Your prescribing provider determines the schedule based on your specific therapeutic goal and cycle structure
Circulating BPC-157 dosage protocols often suggest 200500 micrograms per day for 46 weeks in research settings, usually via injection
US$ 24.49
US$ 20.33
US$ 28.45
US$ 26.33
US$ 23.75
US$ 25.34
US$ 20.73
![Multi Energy (93/100) (Winner League Promo) [EX: Sandstorm] 079](https://cdn.shopify.com/s/files/1/0518/7613/5111/products/e3fc8b99-2cdb-5dd4-8143-60d6f09a9d42_398a9572-1fa2-468e-b250-996a56732394.jpg?v=1696288528)